General Session
Date & Time:
March 24, 2025
8:00 AM – 9:30 AM ET
Format:
In Person & Virtual
CE Credits:
1.5 Hours
UAN: JA0002345-0000-25-043-L99-P
Course level:
Advanced
session objectives:
What You'll Learn
- Summarize the impact of modified fatty acids in the prevention and treatment of PN related complications such as IFALD.
- Discuss the benefit of fish oil in general health and nutrition support.
- Outline the physiology of Specialized Pro-Resolving Mediators and their clinical utility.
Topics & Presenters
Benefit of Modified Fatty Acids
Mark Puder
MD, PhD
Professor of Surgery
Harvard Medical School
Attending Surgeon
Department of Surgery, Boston Children's Hospital
Boston, MA
Is it Time for Bioactive Lipids, EPA and DHA to Take Center Stage in Nutritional Pharmacology Again?
Robert Martindale
MD, PhD, FASPEN
Professor of Surgery
Division of Gastrointestinal and General Surgery, Oregon Health & Science University
Medical Director
Hospital Nutrition Services, Oregon Health & Science University
Portland, OR
Insights Into the Biology of Specialized Pro-Resolving Mediators
Jesmond Dalli
PhD
Professor of Molecular Pharmacology
Barts and The London School of Medicine and Dentistry, Queen Mary University of London
Lipid Mediator Unit Director
William Harvey Research Institute, Queen Mary University of London
London, England United Kingdom
Moderators:
Manpreet Mundi
MDProfessor of Medicine
Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic
Rochester, MN